PSI PHARMACEUTICALS LTDActive
Key figures
Like most small UK companies, PSI PHARMACEUTICALS LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025Balance sheet structure
Filed accounts2022–2025
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Cash at bank and in hand | 342,243 | — | — | — |
| Total assets | 399,842 | 399,548 | 560,741 | 559,728 |
| Total liabilities | — | — | 0 | 0 |
| Net assets / total equity | 399,842 | 399,548 | 605,741 | 604,728 |
| Average number of employees | 2 | 0 | 0 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025Psi Pharmaceuticals is a Group Holding Company/Parent company of Neurone Ltd and PsiClone Ltd, both of which are involved in Research and Development of Pharmaceutical products.
As described in the company's latest filed accounts.
Summary: PSI PHARMACEUTICALS LTD
Company
PSI PHARMACEUTICALS LTD is a private limited company registered with Companies House under company number 13775713. It was incorporated on 1 Dec 2021. Its status is active. The registered office is in Calne (SN11). Its nature of business (SIC 2007) is manufacture of pharmaceutical preparations (21200), research and experimental development on biotechnology (72110).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files micro-entity accounts. Net assets were £604,728, down 0.2% on the previous year. Total assets were £559,728 and total liabilities £0. The company had an average of 0 employees. Figures are available for 4 financial years (2022–2025).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 14 Dec 2026.